CHEK2 variants associate with hereditary prostate cancer (Q36671622)

15 August 2017

CHEK2 variants associate with hereditary prostate cancer (English)

1 reference

15 August 2017

1 reference

8

Schleutker J

1 reference

15 August 2017

Seppälä EH

1

1 reference

15 August 2017

Ikonen T

2

1 reference

15 August 2017

Mononen N

3

1 reference

15 August 2017

Autio V

4

1 reference

15 August 2017

Rökman A

5

1 reference

15 August 2017

Matikainen MP

6

1 reference

15 August 2017

Tammela TL

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

89

1 reference

15 August 2017

10

1 reference

15 August 2017

1966-1970

1 reference

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

Mutations in CHEK2 associated with prostate cancer risk

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

Mutation analysis of the CHK2 gene in families with hereditary breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

Use of population isolates for mapping complex traits

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

A candidate prostate cancer susceptibility gene at chromosome 17p

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

Characterization of tumor-associated Chk2 mutations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394451

Screening hCHK2 for Mutations

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601425

Solid-phase minisequencing as a tool to detect DNA polymorphism

21 January 2018

1 reference

12 December 2020

Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23

1 reference

12 December 2020

Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome

1 reference

12 December 2020

Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors

1 reference

12 December 2020

Germ-line alterations in MSR1 gene and prostate cancer risk

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601425

1 reference

Dimensions Publication ID

15 August 2017

1052868427

0 references

Fatcat ID

release_bsogqwnlgjgzddbswy3khutfuq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bsogqwnlgjgzddbswy3khutfuq

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

PubMed publication ID

14612911

1 reference